O’Melveny & Myers LLP represented CytomX Therapeutics Inc. in the expansion of its Series B round, bringing the total raised to US$41 million.

O’Melveny’s Silicon Valley-based team was led by partners Sam Zucker and Jennifer DePalma and associate Ruchun Ji.

www.omm.com

|



Related Posts:



Leave a Reply